Definitive Contract 75D30122C15140

Award Date 8/30/22
Potential Completion Date 2/28/24
Potential Value $6.2M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Kansas City, MO 64108, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,092,787.07 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract is for COVID-19 research focused on critically ill children and does not have a set-aside designation. Boston Children's Hospital is a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical School. Through this contract, the hospital is...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Seattle Children's Hospital, a non-profit healthcare provider, to conduct a longitudinal study on COVID-19 antibody response in children in Seattle, Washington. The $2,304,624 definitive contract, awarded on June 12, 2020, does not have a set-aside designation and is scheduled for completion by January 31, 2024. As the prime contractor, Seattle Children's Hospital has subcontracted with the Fred...
This is a cost-no-fee delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Children's Hospital Medical Center, a non-profit hospital and research institution located in Cincinnati, Ohio. The contract is part of the Clinical Immunization Safety Assessment (CISA) master indefinite-delivery, indefinite-quantity (IDIQ) contract and has a ceiling value of $697,191.00. The order requires Children's Hospital Medical Center to provide services related to COVID-19 pediatric...
This is a $24,000.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Children's Mercy Hospital, a non-profit pediatric medical center located in Kansas City, Missouri. The contract is for "CLINICAL GRADE LONG READ TARGETED ANALYSIS (PROBAND) SERVICES" and has an ultimate completion date of August 31, 2025. This contract does not have a set-aside designation. Children's Mercy Hospital is a...
This is a $31,468,032.25 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, titled "FLUMED FOR OTHER FUNCTIONS," has a firm fixed-price pricing arrangement and an ultimate completion date of January 30, 2023. The contract does not have a set-aside designation. Through this award, Boston...
This is a $24,899,418.92 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract is for a COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Vaccine Effectiveness (VE) study, with a period of performance ending on September 15, 2026. The contract does not have a set-aside...
This federal contract award to Childrens Hospital Medical Center, a non-profit pediatric hospital and research center in Cincinnati, Ohio, was issued by the Centers for Disease Control and Prevention (CDC). The $716,608 delivery order contract supports the CISA (Clinical Immunization Safety Assessment) RSV INFANTS STUDY, with a period of performance through September 26, 2027. The award does not have a set-aside designation. Childrens Hospital Medical Center has extensive expertise in...
The Centers for Disease Control and Prevention, an agency of the Department of Health and Human Services, awarded a $9,990,604.91 firm fixed price definitive contract to Boston Children's Hospital for MIS-C in Children. As the prime contractor, Boston Children's Hospital will deliver services to investigate Multisystem Inflammatory Syndrome in Children (MIS-C), a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or...
This federal contract award, with a ceiling value of $643,450.00, was issued by the Centers for Disease Control and Prevention (CDC) to the Childrens Hospital Medical Center, a non-profit pediatric hospital and research center located in Cincinnati, Ohio. The contract, titled "METAGENOMIC PREDICTORS," is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation and has an ultimate completion date of September 29, 2017. Childrens...
This federal contract award is for a $518,366 delivery order under the Centers for Disease Control and Prevention's (CDC) Clinical Immunization Safety Assessment (CISA) IDIQ contract. The prime contractor is Childrens Hospital Medical Center (doing business as Children's Home Healthcare), a non-profit pediatric hospital and research center located in Cincinnati, Ohio. The contract is for pediatric COVID-19 vaccination services, with a period of performance through December 2025. No set-aside...

This is a $6,157,849.35 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Children's Mercy Hospital, a non-profit pediatric medical center and research institution located in Kansas City, Missouri. The contract is for a Broad Agency Announcement (BAA) research effort focused on the epidemiology of symptomatic and asymptomatic respiratory viruses, as well as the evaluation of COVID-19 and influenza vaccine effectiveness in K-12 populations. The contract does not have a set-aside designation. This award supports Children's Mercy Hospital's expertise in pediatric healthcare and its involvement in federally-funded research, including studies on consumer product-related injuries, respiratory viral transmission, and smoking cessation. The hospital collaborates with various academic and medical partners on these initiatives, which are intended to advance pediatric health outcomes nationwide.

Generated 3/12/25, 9:57 AM